It's a calmer way to enjoy the web.
Good morning, ladies and gentlemen, and welcome to Veradermic's conference call to discuss results from the female trial arms of Study 207, a Phase II open-label trial evaluating VDPHL01 for mild to ...
If this counts as irony, it might have been an algorithm that pulled me into reading more about the way our digital lives are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results